RGNX logo

REGENXBIO (RGNX) Gross Profit

Annual Gross Profit

$53.03 M
-$5.15 M-8.85%

December 31, 2023

Summary

Performance

1-Year Change

-8.85%

3-Year Change

-55.38%

5-Year Change

-74.61%

15-Year Change

+510.65%

RGNX Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

48.4%
RGNX annual gross profit is higher than 48.4% of companies in Healthcare sector

High & Low

All-time High

$418.51 M
RGNX annual gross profit is currently -87.33% below its historical high of $418.51 million

3-Year Low

$53.03 M
RGNX annual gross profit is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
RGNX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 27, 2025
RGNX next annual earnings announcement is scheduled for Feb 27, 2025

OtherRGNXprofitabilitymetrics:

Annual Gross Margin

58.76%
RGNX annual gross profit margin is 58.76%

Annual Revenue

$90.24 M
RGNX annual revenue is $90.24 million

Annual Net Income

-$263.49 M
RGNX annual net profit is -$263.49 million

Annual EPS

-$6.02
RGNX annual earnings per share is -$6.02

Quarterly Gross Profit

$11.81 M
+$94.00 K+0.80%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

-29.15%

5-Year Change

-3.24%

RGNX Quarterly Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.29%
RGNX quarterly gross profit is higher than 45.29% of companies in Healthcare sector

High & Low

All-time High

$375.60 M
RGNX quarterly gross profit is currently -96.86% below its historical high of $375.60 million

3-Year Low

$6.50 M
RGNX quarterly gross profit is currently +81.66% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RGNX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 27, 2025
RGNX next earnings announcement is scheduled for Feb 27, 2025

OtherRGNXprofitabilitymetrics:

Quarterly Gross Margin

48.81%
RGNX quarterly gross profit margin is 48.81%

Quarterly Revenue

$24.20 M
RGNX quarterly revenue is $24.20 million

Quarterly Net Income

-$59.60 M
RGNX quarterly net profit is -$59.60 million

Quarterly EPS

-$1.17
RGNX quarterly earnings per share is -$1.17

TTM Gross Profit

$45.84 M
-$4.72 M-9.33%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

-15.28%

5-Year Change

+69.83%

RGNX TTM Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.83%
RGNX TTM gross profit is higher than 44.83% of companies in Healthcare sector

High & Low

All-time High

$418.51 M
RGNX TTM gross profit is currently -89.05% below its historical high of $418.51 million

3-Year Low

$45.84 M
RGNX TTM gross profit is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RGNX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 27, 2025
RGNX next earnings announcement is scheduled for Feb 27, 2025

OtherRGNXprofitabilitymetrics:

Annual Gross Margin

58.76%
RGNX annual gross profit margin is 58.76%

TTM Revenue

$84.33 M
RGNX TTM revenue is $84.33 million

TTM Net Income

-$238.81 M
RGNX TTM net profit is -$238.81 million

TTM EPS

-$5.02
RGNX TTM earnings per share is -$5.02

Gross Profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

Annual Gross Profit

$53.03 M
RGNX annual gross profit is $53.03 million

Annual Revenue

$90.24 M
RGNX annual revenue is $90.24 million

Annual Cost Of Goods Sold

$37.21 M
RGNX annual cost of goods sold is $37.21 million

RGNX Gross Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-8.8%0.0%0.0%
3 y3 years-55.4%-29.1%-15.3%
5 y5 years-74.6%-3.2%+69.8%

RGNX Gross Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-87.3%at low-96.9%+81.7%-89.0%at low
5 y5-year-87.3%+96.5%-96.9%+81.7%-89.0%+69.8%
alltimeall time-87.3%+1360.8%-96.9%>+9999.0%-89.0%+9632.5%

REGENXBIO Gross Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
$11.81 M(+0.8%)
$45.84 M(-9.3%)
Jun 2024
-
$11.72 M(+3.3%)
$50.56 M(+2.5%)
Mar 2024
-
$11.34 M(+3.3%)
$49.34 M(-7.0%)
Dec 2023
$53.03 M(-8.9%)
$10.97 M(-33.6%)
$53.03 M(-12.5%)
Sep 2023
-
$16.53 M(+57.4%)
$60.62 M(+5.4%)
Jun 2023
-
$10.50 M(-30.1%)
$57.51 M(-13.8%)
Mar 2023
-
$15.03 M(-19.0%)
$66.70 M(+14.7%)
Dec 2022
$58.18 M(-86.1%)
$18.56 M(+38.3%)
$58.18 M(-86.0%)
Sep 2022
-
$13.42 M(-31.9%)
$415.21 M(-0.8%)
Jun 2022
-
$19.70 M(+203.0%)
$418.46 M(+1.8%)
Mar 2022
-
$6.50 M(-98.3%)
$410.98 M(-1.8%)
Dec 2021
$418.51 M(+252.1%)
$375.60 M(+2153.4%)
$418.51 M(+673.5%)
Sep 2021
-
$16.67 M(+36.4%)
$54.10 M(-54.5%)
Jun 2021
-
$12.22 M(-12.9%)
$118.98 M(+0.3%)
Mar 2021
-
$14.03 M(+25.4%)
$118.65 M(-0.2%)
Dec 2020
$118.85 M(+340.3%)
$11.19 M(-86.3%)
$118.85 M(+2.8%)
Sep 2020
-
$81.55 M(+586.3%)
$115.64 M(+149.8%)
Jun 2020
-
$11.88 M(-16.5%)
$46.30 M(+14.7%)
Mar 2020
-
$14.23 M(+78.5%)
$40.37 M(+49.6%)
Dec 2019
$26.99 M
$7.98 M(-34.6%)
$26.99 M(-52.6%)
Sep 2019
-
$12.21 M(+105.0%)
$56.95 M(+15.0%)
DateAnnualQuarterlyTTM
Jun 2019
-
$5.95 M(+596.4%)
$49.53 M(-37.9%)
Mar 2019
-
$855.00 K(-97.7%)
$79.74 M(-61.8%)
Dec 2018
$208.87 M(+2305.2%)
$37.93 M(+692.1%)
$208.87 M(+20.5%)
Sep 2018
-
$4.79 M(-86.8%)
$173.35 M(+2.4%)
Jun 2018
-
$36.16 M(-72.2%)
$169.22 M(+22.4%)
Mar 2018
-
$129.98 M(+5266.8%)
$138.30 M(+1492.6%)
Dec 2017
$8.68 M(+139.2%)
$2.42 M(+270.9%)
$8.68 M(+13.8%)
Sep 2017
-
$653.00 K(-87.6%)
$7.63 M(+8.0%)
Jun 2017
-
$5.25 M(+1340.9%)
$7.07 M(+91.1%)
Mar 2017
-
$364.00 K(-73.4%)
$3.70 M(+1.8%)
Dec 2016
$3.63 M(-40.3%)
$1.37 M(+1417.8%)
$3.63 M(-37.7%)
Sep 2016
-
$90.00 K(-95.2%)
$5.83 M(-12.0%)
Jun 2016
-
$1.88 M(+532.0%)
$6.62 M(+14.2%)
Mar 2016
-
$297.00 K(-91.7%)
$5.80 M(-4.8%)
Dec 2015
$6.08 M(+19.0%)
$3.57 M(+303.9%)
$6.09 M(+72.9%)
Sep 2015
-
$883.00 K(-16.1%)
$3.52 M(+13.2%)
Jun 2015
-
$1.05 M(+78.2%)
$3.11 M(+51.1%)
Mar 2015
-
$591.00 K(-40.7%)
$2.06 M(+40.3%)
Dec 2014
$5.11 M(-11.3%)
$997.00 K(+111.7%)
$1.47 M(+211.7%)
Sep 2014
-
$471.00 K
$471.00 K
Dec 2013
$5.76 M
-
-

FAQ

  • What is REGENXBIO annual gross profit?
  • What is the all time high annual gross profit for REGENXBIO?
  • What is REGENXBIO annual gross profit year-on-year change?
  • What is REGENXBIO quarterly gross profit?
  • What is the all time high quarterly gross profit for REGENXBIO?
  • What is REGENXBIO quarterly gross profit year-on-year change?
  • What is REGENXBIO TTM gross profit?
  • What is the all time high TTM gross profit for REGENXBIO?
  • What is REGENXBIO TTM gross profit year-on-year change?

What is REGENXBIO annual gross profit?

The current annual gross profit of RGNX is $53.03 M

What is the all time high annual gross profit for REGENXBIO?

REGENXBIO all-time high annual gross profit is $418.51 M

What is REGENXBIO annual gross profit year-on-year change?

Over the past year, RGNX annual gross profit has changed by -$5.15 M (-8.85%)

What is REGENXBIO quarterly gross profit?

The current quarterly gross profit of RGNX is $11.81 M

What is the all time high quarterly gross profit for REGENXBIO?

REGENXBIO all-time high quarterly gross profit is $375.60 M

What is REGENXBIO quarterly gross profit year-on-year change?

Over the past year, RGNX quarterly gross profit has changed by $0.00 (0.00%)

What is REGENXBIO TTM gross profit?

The current TTM gross profit of RGNX is $45.84 M

What is the all time high TTM gross profit for REGENXBIO?

REGENXBIO all-time high TTM gross profit is $418.51 M

What is REGENXBIO TTM gross profit year-on-year change?

Over the past year, RGNX TTM gross profit has changed by $0.00 (0.00%)